Long-term safety and effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study

被引：0

作者：

Kiani, Sorena ^{[1
]}

Wu, Adrian ^{[2
]}

Peter, Jonathan ^{[3
]}

Reshef, Avner ^{[4
]}

Maurer, Marcus ^{[5
]}

Stobiecki, Marcin ^{[6
]}

Kinaciyan, Tamar ^{[7
]}

Aygoeren-Puersuen, Emel ^{[8
]}

Best, Jessica ^{[9
]}

Cornpropst, Melanie ^{[9
]}

Sheridan, William P. ^{[9
]}

Farkas, Henriette ^{[10
]}

机构：

[1] Barts Hlth NHS Trust, London, England

[2] Ctr Asthma & Allergy, Hing Kong, Peoples R China

[3] Univ Cape Town, Allergy & Immunol Unit, Lung Inst, Cape Town, South Africa

[4] Barzilai Govt Hosp, Ashqelon, Israel

[5] Charite, Berlin, Germany

[6] Jagiellonian Univ, Med Coll, Krakow, Poland

[7] Med Univ Vienna, Vienna, Austria

[8] Goethe Univ, Univ Hosp Frankfurt, Frankfurt, Germany

[9] BioCryst Pharmaceut Inc, Durham, NC USA

[10] Semmelweis Univ, Budapest, Hungary

来源：

CLINICAL AND EXPERIMENTAL ALLERGY | 2021年 / 51卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

P033

引用

页码：172 / 173

页数：2

共 50 条

[31] Efficacy and safety of long-term prophylaxis with C1 inhibitor (C1INH) concentrate in patients with hereditary Angioedema (HAE)
Uraw, B.
Busse, P.
White, M.
Jacobs, J.
Lumry, W.
Baker, J.
Hurewitz, D.
Manning, M.
Koleilat, M.
Friedman, R. A.
Wilkinson, R.
Cartwright, W. E.
Tanner, D.
Kohler, G.
Gunther, G.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S272 - S272
[32] Lanadelumab safety and efficacy in hereditary angioedema after switching from prior long-term prophylaxis: analysis from the HELP OLE study
Mansour, E.
Bernstein, J.
Riedl, M.
Kiani, S.
Aygoren-Pursun, E.
Choudhry, Z.
Jain, S.
Nurse, C.
Yegin, A.
Banerji, A.
[J]. ALLERGY, 2023, 78 : 12 - 12
[33] Patterns of Treatment and Retreatment of Acute Attacks of Hereditary Angioedema (HAE) with Standard of Care (SOC) On-Demand Medication: Results from the APeX-2 Study
Aygoren-Pursun, Emel
Johnston, Douglas
Lumry, William
Li, Huamin
Banerji, Aleena
Zuraw, Bruce
Christiansen, Sandra
Kinaciyan, Tamar
Hanzlikova, Jana
Gower, Richard
Gagnon, Remi
Cicardi, Marco
Cornpropst, Melanie
Dobo, Sylvia
Hutchinson, Kathryn
Iocca, Heather
Nagy, Eniko
Murray, Sharon
Sheridan, William
Bernstein, Jonathan
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB107 - AB107
[34] Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey
Maurer, M.
Longhurst, H. J.
Bouillet, L.
Caballero, T.
Grumach, A. S.
Botha, J.
Andresen, I
Aberer, W.
[J]. ALLERGY, 2020, 75 : 59 - 60
[35] Efficacy and Safety of Subcutaneous Garadacimab for the Prophylaxis of Hereditary Angioedema Attacks in Adults and Adolescent Patients with HAE: Results from a Multicenter, Placebo-Controlled Phase 3 Trial
Craig, Timothy
Magerl, Markus
Reshef, Avner
Li, Huamin
Jacobs, Joshua
Bernstein, Jonathan
Farkas, Henriette
Yang, William
Stroes, Erik
Ohsawa, Isao
Tachdjian, Raffi
Manning, Michael
Lumry, William
Saguer, Inmaculada Martinez
Aygoeren-Puersuen, Emel
Ritchie, Bruce
Sussman, Gordon
Anderson, John
Kawahata, Kimito
Suzuki, Yusuke
Staubach, Petra
Treudler, Regina
Feuersenger, Henrike
Wieman, Lolis
Jacobs, Iris
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB132 - AB132
[36] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
Aberer, Werner
Maurer, Marcus
Bouillet, Laurence
Zanichelli, Andrea
Caballero, Teresa
Longhurst, Hilary J.
Perrin, Amandine
Andresen, Irmgard
[J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
[37] Long-Term Effectiveness and Safety of Lanadelumab in Patients With Hereditary Angioedema From the United States and Canada: Final Data From the EMPOWER Study
Bernstein, Jonathan
Betschel, Stephen
Busse, Paula
Banerji, Aleena
Baptist, Alan
Craig, Timothy
Goodyear, M. Dawn
Manning, Michael
Petroni, Daniel
Wedner, H. James
Khutoryansky, Natalie
Juethner, Salome
Estepan, Daniel Nova
Watt, Maureen
Zuraw, Bruce
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB242 - AB242
[38] Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
Werner Aberer
Marcus Maurer
Laurence Bouillet
Andrea Zanichelli
Teresa Caballero
Hilary J. Longhurst
Amandine Perrin
Irmgard Andresen
[J]. Allergy, Asthma & Clinical Immunology, 13
[39] An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension
Riedl, Marc A.
Bernstein, Jonathan A.
Craig, Timothy
Banerji, Aleena
Magerl, Markus
Cicardi, Marco
Longhurst, Hilary J.
Shennak, Mustafa M.
Yang, William H.
Schranz, Jennifer
Baptista, Jovanna
Busse, Paula J.
[J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2017, 7
[40] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: Final Results From the HELP Open-Label Extension Study
Paes, Kim
Bernstein, Jonathan
Longhurst, Hilary
Aygoren-Pursun, Emel
Ren, Hong
Craig, Timothy
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB145 - AB145

← 1 2 3 4 5 →